Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistThe Skin Atelier, Inc. (operating as Skinprint) received an FDA Warning Letter on October 1, 2019, regarding drug products. Based on the limited metadata available, the specific violations cannot be detailed as the subject line is not provided. The letter was issued under the FDA's drug regulatory authority, though the specific issuing office is unknown. Without access to the full warning letter text, the precise nature of the compliance issues and required corrective actions cannot be determined from this metadata alone.